Sayed Tabatabaei Mahsa, Sayed Tabatabaei Fakhredin A, Moghimi Hamid Reza
Department of Pharmaceutics and Nanotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Medicines Evaluation Board, Utrecht, The Netherlands.
Bioimpacts. 2024 Oct 27;15:30161. doi: 10.34172/bi.30161. eCollection 2025.
Drug self-delivery systems are nanostructures composed of a drug as the main structural unit, having the ability of intracellular trafficking with no additional carrier. In these systems, the drug itself undertakes the functional and structural roles; thereby, the ancillary role of excipients and carrier-related limitations are circumvented and therapeutic effect is achieved at a much lower dose. Such advantages -which are mainly but not exclusively beneficial in cancer treatment- have recently led to an upsurge of research on these systems. Subsequently, various terminologies were utilized to describe them, referring to the same concept with different words. However, not all the systems developed based on the self-delivery approach are introduced using one of these keywords. Using a scoping strategy, this review aims to encompass the systems that have been developed as yet -inspired by the concept of self-delivery- and classify them in a coherent taxonomy. Two main groups are introduced based on the type of building blocks: small molecule-based nanomedicines and self-assembling hybrid prodrugs. Due to the diversity, covering the whole gamut of topics is beyond the scope of a single article, and, inevitably, the latter is just briefly introduced here, whereas the features of the former group are meticulously presented. Depending on whether the drug is merely a carrier for itself or carries a second drug as cargo, two classes of small molecule-based nanomedicines are defined (i.e., pure nanodrugs and carrier-mimicking systems, respectively), each having sub-branches. After introducing each branch and giving some examples, possible strategies for designing each particular system are visually displayed. The resultant mind map can create a macro view of the taken path and its prospects, give a profound insight into opportunities, spark new ideas, and facilitate overcoming obstacles. Taken together, one can foresee a brilliant future for self-delivery systems as a pioneering candidate for the next generation of drug delivery systems.
药物自递送系统是由药物作为主要结构单元组成的纳米结构,无需额外载体即可进行细胞内运输。在这些系统中,药物本身承担功能和结构角色;因此,辅料的辅助作用和与载体相关的限制得以规避,并且以低得多的剂量即可实现治疗效果。这些优势——主要但不限于在癌症治疗中有益——最近引发了对这些系统的研究热潮。随后,人们使用了各种术语来描述它们,用不同的词指代相同的概念。然而,并非所有基于自递送方法开发的系统都使用这些关键词之一来介绍。本综述采用一种范围界定策略,旨在涵盖受自递送概念启发迄今已开发的系统,并将它们分类成一个连贯的分类法。根据构建模块的类型引入了两个主要类别:基于小分子的纳米药物和自组装杂合前药。由于内容的多样性,涵盖所有主题超出了一篇文章的范围,不可避免地,后者在此仅作简要介绍,而前者的特征则进行了详细阐述。根据药物本身只是载体还是携带第二种药物作为负载,定义了两类基于小分子的纳米药物(即分别为纯纳米药物和模拟载体系统),每类都有子分支。在介绍每个分支并给出一些示例后,直观展示了设计每个特定系统的可能策略。由此生成的思维导图可以创建所走路径及其前景的宏观视图,深入洞察机会,激发新想法,并有助于克服障碍。综上所述,可以预见自递送系统作为下一代药物递送系统的先驱候选者将拥有光明的未来。